Inovio Gets Grant for Ebola Drugs, Regeneron Inks Deal

The company is currently evaluating its Ebola vaccine, INO-4212, in a phase I study. Interim safety and immune response data should mature in the … Full Article http://j.gs/5sTq

Click here to read full article